Vimarsana
Biggest News Aggregation in the World

Page 12 - Sny News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sny Today - Breaking & Trending Today

Analysts Set Sanofi (NASDAQ:SNY) Price Target at $60.00 - Vimarsana News

Analysts Set Sanofi (NASDAQ:SNY) Price Target at $60.00

Shares of Sanofi (NASDAQ:SNY – Get Free Report) have received an average rating of “Hold” from the seven brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have assigned a buy recommendation to the company. […]

Source: wkrb13.com
Lawmakers Seek More Changes to NYC's Street Vending Rules - Vimarsana News

Lawmakers Seek More Changes to NYC's Street Vending Rules

Two years after the passage of Local Law 18—intended to overhaul street vending regulations and add hundreds of additional licenses to the market each year—councilmembers are weighing another package of changes, including one bill that would lift the cap on licenses altogether.

BROOKFIELD Corp ON Acquires 75,741 Shares of Sanofi (NASDAQ:SNY) - Vimarsana News

BROOKFIELD Corp ON Acquires 75,741 Shares of Sanofi (NASDAQ:SNY)

BROOKFIELD Corp ON grew its holdings in Sanofi (NASDAQ:SNY – Free Report) by 14.3% during the 2nd quarter, Holdings Channel reports. The fund owned 605,652 shares of the company’s stock after buying an additional 75,741 shares during the period. BROOKFIELD Corp ON’s holdings in Sanofi were worth $32,645,000 as of its most recent filing with […]

Camber Capital Management LP Sells 1,500,000 Shares of Sanofi (NASDAQ:SNY) - Vimarsana News

Camber Capital Management LP Sells 1,500,000 Shares of Sanofi (NASDAQ:SNY)

Camber Capital Management LP reduced its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 27.3% in the second quarter, Holdings Channel reports. The institutional investor owned 4,000,000 shares of the company’s stock after selling 1,500,000 shares during the period. Sanofi makes up 7.0% of Camber Capital Management LP’s investment portfolio, making the stock […]

Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials - Vimarsana News

Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials

By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...